| Normal range | All patients |  | Develop DIC | No DIC |  |
---|---|---|---|---|---|---|
 |  | Median level | Abnormal patients (%) | Median level | Median level | P- value* |
Global markers | Â | Â | Â | Â | Â | Â |
  Platelet (× 103/μL) | 130 to 369 | 163 (118 to 205) | 33.8a | 140 (108 to 184) | 176 (136 to 228) | 0.036 |
  PT-INR | 0.9 to 1.2 | 1.25 (1.15 to 1.37) | 55.8b | 1.29 (1.17 to 1.38) | 1.21 (1.13 to 1.31) | 0.091 |
  APTT (sec) | 23.1 to 36.3 | 39.5 (32.2 to 48.9) | 62.3b | 42.7 (35.4 to 49.5) | 37.7 (31.3 to 42.7) | 0.096 |
  Fibrinogen (mg/dL) | 129 to 371 | 395 (249 to 544) | 25.9a | 299 (225 to 481) | 419 (319 to 565) | 0.041 |
  FDP (μg/mL) | 0 to 5.0 | 16.7 (10.4 to 28.9) | 97.4b | 20.5 (11.7 to 44.1) | 15.6 (8.4 to 22.1) | 0.011 |
Thrombin generation | Â | Â | Â | Â | Â | Â |
  TAT (ng/mL) | <2.4 | 12.5 (7.2 to 20.1) | 98.7b | 19.5 (10.5 to 25.8) | 8.4 (5.7 to 12.9) | <0.0001 |
  SF (μg/mL) | <7.0 | 10.5 (5.3 to 24.2) | 66.2b | 13.9 (7.9 to 29.3) | 7.4 (3.2 to 17.3) | 0.013 |
Anticoagulant activity | Â | Â | Â | Â | Â | Â |
  PC (%) | 67 to 129 | 46.2 (34.1 to 59.5) | 88.3a | 36.6 (28.1 to 44.9) | 59.1 (46.7 to 65.6) | <0.0001 |
  AT (%) | 75 to 125 | 51.8 (38.4 to 63.2) | 88.3a | 42.8 (31.3 to 54.8) | 58.2 (48.1 to 72.5) | 0.0001 |
Fibrinolytic activity | Â | Â | Â | Â | Â | Â |
  Plasminogen (%) | 85 to 120 | 60.2 (43.6 to 73.7) | 85.7a | 48.1 (30.3 to 66.1) | 67.0 (57.1 to 84.6) | 0.0001 |
  α2-PI (%) | 83 to 115 | 67.3 (52.1 to 82.8) | 74.1a | 54.1 (40.5 to 67.6) | 78.6 (67.1 to 88.7) | <0.0001 |
  PAI-1 (ng/mL) | <50.0 | 154.7 (60.7 to 533.1) | 81.8b | 531.6 (191.1 to 992.6) | 77.6 (40.8 to 154.7) | <0.0001 |
  PIC (μg/mL) | <0.9 | 1.0 (0.7 to 1.8) | 54.5b | 1.0 (0.6 to 2.7) | 1.1 (0.8 to 1.5) | 0.99 |
Endothelial activation | Â | Â | Â | Â | Â | Â |
  sES (ng/mL) | <29.7 | 55.2 (35.9 to 101.1) | 83.1b | 65.3 (34.8 to 144.8) | 49.5 (36.9 to 72.9) | 0.17 |